Monoclonal antibodies against MERS coronavirus show promise in phase 1 NIH-sponsored trial
Credit: NIAID and Colorado State University WHAT: A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes...